Investigator Responsibilities – Safety Reporting for Investigational Drugs and Devices | FDA – FDA.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GUIDANCE DOCUMENT
Not for implementation. Contains non-binding recommendations.
This guidance is intended to help clinical investigators comply with the following safety reporting requirements:
Recommendations are provided to help investigators identify the following:
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document’s docket number: FDA-2021-D-0368.
09/28/2021
Search for FDA
Guidance Documents

source

Leave a Comment

Your email address will not be published.

Shopping Cart